ALBO
Barclays’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-6,163
| Closed | -$134K | – | 4570 |
|
2022
Q4 | $134K | Buy |
6,163
+4,160
| +208% | +$90.4K | ﹤0.01% | 3304 |
|
2022
Q3 | $39K | Buy |
2,003
+1,138
| +132% | +$22.2K | ﹤0.01% | 3736 |
|
2022
Q2 | $17K | Sell |
865
-1,952
| -69% | -$38.4K | ﹤0.01% | 4165 |
|
2022
Q1 | $84K | Sell |
2,817
-17,663
| -86% | -$527K | ﹤0.01% | 3750 |
|
2021
Q4 | $477K | Buy |
20,480
+13,523
| +194% | +$315K | ﹤0.01% | 2551 |
|
2021
Q3 | $217K | Buy |
6,957
+4,599
| +195% | +$143K | ﹤0.01% | 2946 |
|
2021
Q2 | $83K | Sell |
2,358
-15,712
| -87% | -$553K | ﹤0.01% | 3202 |
|
2021
Q1 | $637K | Buy |
18,070
+8,693
| +93% | +$306K | ﹤0.01% | 2543 |
|
2020
Q4 | $352K | Sell |
9,377
-638
| -6% | -$24K | ﹤0.01% | 2482 |
|
2020
Q3 | $334K | Buy |
10,015
+2,699
| +37% | +$90K | ﹤0.01% | 2501 |
|
2020
Q2 | $195K | Buy |
7,316
+3,150
| +76% | +$84K | ﹤0.01% | 2816 |
|
2020
Q1 | $68K | Sell |
4,166
-6,719
| -62% | -$110K | ﹤0.01% | 2970 |
|
2019
Q4 | $277K | Buy |
10,885
+5,521
| +103% | +$140K | ﹤0.01% | 3016 |
|
2019
Q3 | $107K | Sell |
5,364
-1,294
| -19% | -$25.8K | ﹤0.01% | 3372 |
|
2019
Q2 | $215K | Buy |
6,658
+3,982
| +149% | +$129K | ﹤0.01% | 3160 |
|
2019
Q1 | $86K | Buy |
2,676
+2,523
| +1,649% | +$81.1K | ﹤0.01% | 3408 |
|
2018
Q4 | $4K | Sell |
153
-3,375
| -96% | -$88.2K | ﹤0.01% | 3810 |
|
2018
Q3 | $117K | Buy |
3,528
+2,861
| +429% | +$94.9K | ﹤0.01% | 3330 |
|
2018
Q2 | $23K | Sell |
667
-5,226
| -89% | -$180K | ﹤0.01% | 3587 |
|
2018
Q1 | $192K | Sell |
5,893
-807
| -12% | -$26.3K | ﹤0.01% | 2858 |
|
2017
Q4 | $172K | Buy |
+6,700
| New | +$172K | ﹤0.01% | 2728 |
|
2014
Q1 | – | Hold |
0
| – | – | – | 4428 |
|
2013
Q4 | – | Hold |
0
| – | – | – | 4446 |
|
2013
Q3 | – | Sell |
-87
| Closed | – | – | 4331 |
|
2013
Q2 | $0 | Buy |
+87
| New | – | ﹤0.01% | 4362 |
|